NSN 6505-01-656-4667 (6505016564667) Fentanyl Transdermal System - NSN Parts Catalog

NSN 6505-01-656-4667 is manufactured by Mylan Pharmaceuticals Inc, Par Pharmaceutical Inc, Janssen Pharmaceuticals Inc, Sandoz Inc, Mallinckrodt Inc and is a Fentanyl Transdermal System. Ready to submit an RFQ? Simply utilize our instant RFQ form to get started. With the fastest lead times in the industry, you can expect to receive a quote in 15 minutes or less. If your required item is a part number related to NDC00378-9123-98, NDC49884-0763-78, NDC50458-0093-05, NDC00781-7243-55, NDC00406-9075-76, we can help! Our product portfolio encompassing NSN 6505-01-656-4667 is listed below, along with associated NSN parts.

Veritable Aerospace, owned and operated by ASAP Semiconductor LLC, is dedicated to simplifying your purchasing experience. Our extensive supply-chain network allows us to provide access over 3 billion high-quality parts from trusted manufacturers, right at your fingertips.

Item Name	Fentanyl Transdermal System
National Item Identification Number (NIIN)	01-656-4667 (016564667)

Part Number	Manufacturer	Item Name	RFQ
NDC00378-9123-98	mylan pharmaceuticals inc	fentanyl transdermal system	RFQ
NDC49884-0763-78	par pharmaceutical inc	fentanyl transdermal system	RFQ
NDC50458-0093-05	janssen pharmaceuticals inc	fentanyl transdermal system	RFQ
NDC00781-7243-55	sandoz inc	fentanyl transdermal system	RFQ
NDC00406-9075-76	mallinckrodt inc	fentanyl transdermal system	RFQ
NDC00591-3213-72	actavis pharma inc	fentanyl transdermal system	RFQ

Technical Characteristics of NSN 6505016564667

MRC	Criteria	Characteristic
FEAT	Special Features	ROUTE: TRANSDERMAL; DOSE FORM: PATCH, TRANSDERMAL 72 HOURS; STRENGTH: 75 MCG/HOUR; DEA CONTROLLED II SUBSTANCE; INDIVIDUALLY SEALED; CONTAINS FIVE (75 MCG/HR) TRANSDERMAL SYSTEMS; STORE IN ORIGINAL UNOPENED POUCH. STORE UP TO 20 C TO 25 C (68 F TO 77 F; STRICT ADHERENCE TO THE RECOMMENDED HANDLING AND DISPOSAL INSTRUCTIONS ON PRODUCT INSERT IS OF THE UTMOST IMPORTANCE TO PREVENT ACCIDENTAL EXPOSURE; EXPOSURE OF FENTANYL TRANSDERMAL SYSTEM APPLICATION SITE AND SURROUNDING AREA TO DIRECT EXTERNAL HEAT SOURCES, SUCH AS HEATING PADS, SAUNAS, HOT TUBS AND HEATED WATER BEDS MAY INCREASE FENTANYL ABSORPTION AND RESULT IN FATAL OVERDOSE OF FENTANYL AND DEATH; PATIENTS WHO DEVELOP FEVER OR INCREASED CORE BODY TEMPERATURE DUE TO STRENOUS EXERTION ARE ALSO AT RISK FOR INCREASED FENTANYL EXPOSURE AND MAY REQUIRE AN ADJUSTMENT IN THE DOSE OF FENTANYL TRANSDERMAL SYSTEM TO AVOID OVERDOSE
CSLZ	Usual Dose	75 MCG/HR
CBBL	Features Provided	INDIVIDUALLY SEALED
CRYC	Controlled Substance Classification	SCHEDULE II
CXCY	Part Name Assigned By Controlling Agency	DURAGESIC-75 (FENTANYL TRANSDERMAL SYSTEM) 75MCG/HR, 5S
MRC	Decoded Requirement	Clear Text Reply

Relevant Components for NSN - 6505-01-656-4667, 6505016564667
6505-00-001-3345 (6505000013345)	6505-00-001-7673 (6505000017673)	6505-00-001-7674 (6505000017674)	6505-00-001-7676 (6505000017676)
6505-00-001-9186 (6505000019186)	6505-00-003-3022 (6505000033022)	6505-00-003-3026 (6505000033026)	6505-00-003-5111 (6505000035111)
6505-00-003-5112 (6505000035112)	6505-00-003-5116 (6505000035116)	6505-00-004-6652 (6505000046652)	6505-00-004-6656 (6505000046656)